Oral squamous cell carcinoma (OSCC) remains difficult to treat because of its intricate molecular profile, its limited responsiveness to conventional therapeutic approaches, and the challenge of targeting key oncogenic drivers with standard drugs. An emerging ... ...

请注册登录后继续浏览